Literature DB >> 29170860

γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery.

Maria Franzini1, Veronica Musetti1, Daniela Guarino2, Laura Caponi1, Aldo Paolicchi1, Michele Emdin3,4, Ele Ferrannini5, Monica Nannipieri6.   

Abstract

BACKGROUND/
OBJECTIVES: Gamma-glutamyltranspeptidase (GGT) levels are an independent risk marker for the development of type 2 diabetes (T2DM). We investigated the relationship between the newly identified serum GGT fractions and glucose metabolism in obese subjects before and after bariatric surgery. SUBJECTS/
METHODS: Twenty-nine T2DM subjects, wait-listed for Roux-en-Y gastric bypass (RYGB; n = 21) or laparoscopic sleeve gastrectomy (LSG; n = 8), received a 5-h mixed meal test before (T0), 15 days (T15), and 1 year after surgery (T365). Insulin sensitivity was assessed by the OGIS index and β-cell function by C-peptide analysis; fractional GGT (b-, s-, m-, and f-GGT) analysis was performed by gel-filtration chromatography.
RESULTS: At T15, total GGT activity decreased by 40% after LSG (p = 0.007) but remained unchanged after RYGB. At T365, all patients showed a reduction in total GGT, in particular b-GGT (≥ 60%) and m-GGT (≥ 50%). In patients with biopsy-proven steatohepatitis (n = 10), total, b-, s-, and m-GGT fractions at T0 were significantly higher than in patients with low-grade steatosis (p = 0.016, 0.0003, and 0.005, respectively); at T365, there was a significant fall in total GGT as well as in each fraction in both groups. In a multiple regression model, b-GGT was the only fraction related to insulin sensitivity (p = 0.016; β coeff. = - 14.0) independently of BMI, fasting glucose, and triglycerides.
CONCLUSIONS: While GGT activity is generally associated with impaired glucose metabolism, fractional GGT analysis showed that the b-GGT fraction specifically and independently tracks with insulin resistance.

Entities:  

Keywords:  B-GGT fraction; Gamma-glutamyltransferase; Insulin sensitivity; NASH

Mesh:

Substances:

Year:  2018        PMID: 29170860     DOI: 10.1007/s11695-017-3017-7

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  41 in total

1.  Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

Authors:  Sasiwarang Goya Wannamethee; Andrew Gerald Shaper; Lucy Lennon; Peter H Whincup
Journal:  Diabetes Care       Date:  2005-12       Impact factor: 19.112

Review 2.  The effect of bariatric surgeries on nonalcoholic fatty liver disease.

Authors:  Mazen Hassanian; Amnah Al-Mulhim; Atheer Al-Sabhan; Shaden Al-Amro; Fahad Bamehriz; Ayman Abdo; Hisham Al Khalidi; Tamader A Aldoheyan
Journal:  Saudi J Gastroenterol       Date:  2014 Sep-Oct       Impact factor: 2.485

3.  Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.

Authors:  Elfriede Ruttmann; Larry J Brant; Hans Concin; Günter Diem; Kilian Rapp; Hanno Ulmer
Journal:  Circulation       Date:  2005-09-26       Impact factor: 29.690

4.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2014-03-31       Impact factor: 91.245

5.  gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women.

Authors:  Duk Hee Lee; Karri Silventoinen; David R Jacobs; Pekka Jousilahti; Jaakko Tuomileto
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

6.  Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.

Authors:  Douglas S Lee; Jane C Evans; Sander J Robins; Peter W Wilson; Irene Albano; Caroline S Fox; Thomas J Wang; Emelia J Benjamin; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-09       Impact factor: 8.311

7.  Increased Bile Acid Synthesis and Deconjugation After Biliopancreatic Diversion.

Authors:  Ele Ferrannini; Stefania Camastra; Brenno Astiarraga; Monica Nannipieri; Jose Castro-Perez; Dan Xie; Liangsu Wang; Manu Chakravarthy; Rebecca A Haeusler
Journal:  Diabetes       Date:  2015-05-26       Impact factor: 9.461

Review 8.  A Systematic Review and Meta-analysis of the Effect of Gastric Bypass Surgery on Plasma Lipid Levels.

Authors:  Kirstin A Carswell; Ajay P Belgaumkar; Stephanie A Amiel; Ameet G Patel
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

9.  Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial.

Authors:  Piotr Kalinowski; Rafał Paluszkiewicz; Bogna Ziarkiewicz-Wróblewska; Tadeusz Wróblewski; Piotr Remiszewski; Mariusz Grodzicki; Marek Krawczyk
Journal:  Ann Surg       Date:  2017-11       Impact factor: 12.969

10.  Different associations between obesity and impaired fasting glucose depending on serum gamma-glutamyltransferase levels within normal range: a cross-sectional study.

Authors:  Nam Soo Hong; Jeong-Gook Kim; Yu-Mi Lee; Hyun-Woo Kim; Sin Kam; Keon-Yeop Kim; Ki-Su Kim; Duk-Hee Lee
Journal:  BMC Endocr Disord       Date:  2014-07-12       Impact factor: 2.763

View more
  4 in total

Review 1.  Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis.

Authors:  Miller Barreto de Brito E Silva; Francisco Tustumi; Antonio Afonso de Miranda Neto; Anna Carolina Batista Dantas; Marco Aurélio Santo; Ivan Cecconello
Journal:  Obes Surg       Date:  2021-04-13       Impact factor: 4.129

2.  Liver function markers predict cardiovascular and renal outcomes in the CANVAS Program.

Authors:  Giulia Ferrannini; Norman Rosenthal; Michael K Hansen; Ele Ferrannini
Journal:  Cardiovasc Diabetol       Date:  2022-07-04       Impact factor: 8.949

3.  Survival advantage associated with metformin usage in hepatocellular carcinoma patients with diabetes mellitus receiving radical resection: a propensity score matching analysis.

Authors:  Cui-Song Luo; Yun Lin; Wei-Ping Zhou; Jun Shi
Journal:  Eur J Gastroenterol Hepatol       Date:  2020-08       Impact factor: 2.586

Review 4.  Scientific Advances in Diabetes: The Impact of the Innovative Medicines Initiative.

Authors:  Maria de Fátima Brito; Carla Torre; Beatriz Silva-Lima
Journal:  Front Med (Lausanne)       Date:  2021-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.